Filing Flows › Glaukos (GKOS) › Q2 2026
Glaukos (GKOS) Q2 2026 earnings results (second quarter 2026)
10-Q filed Jul 29, 2026
Glaukos (GKOS) reported revenue of $186M for the second quarter 2026 (Q2 2026), +50% from a year earlier and +23% from the quarter before. Operating margin was -9.3%, net loss $18.4M (9.9% of revenue).
Glaukos, Q2 2026: revenue $186M (+50% year over year), operating margin -9.3%, net loss $18.4M, operating cash flow $14.8M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $186M | +23% | +50% |
| Operating profit | −$17.3M | — | — |
| Net earnings | −$18.4M | — | — |
| Operating cash flow | $14.8M | — | +112% |
| Free cash flow | $12.1M | — | +108% |
What changed
Revenue was $185.6M in Q2 2026, up 50% year over year and up 23% from the previous quarter. Glaucoma was the largest line at 84% of revenue. Glaucoma added $51.6M year over year (up 50%), 84% of the total change.
Gross margin was 81.7%, up 3.3 points from Q2 2025. Operating costs exceeded revenue by $17.3M, an operating margin of -9.3%. Operating expenses grew 41% against revenue growth of 50%. The fastest-growing cost line was Research & development (+40%). The quarter ended with a net loss of $18.4M, narrower than the previous quarter's $19.8M loss.
Operating cash flow was $14.8M (up 112% year over year). Non-cash charges added back $8.9M of depreciation and amortization and $28.9M of share-based compensation. Working capital and other items used $4.5M. Capital expenditures of $2.7M left free cash flow of $12.1M.
Questions
What was Glaukos' revenue in the second quarter 2026?
Glaukos (GKOS) reported revenue of $186M for the second quarter 2026 (Q2 2026), +50% from a year earlier and +23% from the quarter before.
Was Glaukos profitable in the second quarter 2026?
Operating loss was $17.3M (-9.3% of revenue) and net loss $18.4M.
Source: Glaukos 10-Q on SEC EDGAR.